Priorix Vaccine

Priorix Vaccine is a prescription based medicine. It is a combination of three vaccines such as Measles Vaccine (Live) (1000ccid50), Mumps Virus Vaccine (5000ccid50), and Rubella vaccine (Live) (1000ccid50). It is used to prevent measles, mumps, and rubella. It works by stimulating the immune system to act against microorganisms to prevent such types of infection. As these infections can occur in people of any age group so it is essential to take vaccine against them.

• Prevention of Measles
• Prevention of Rubella
• Prevention of Mumps

Most side effects of Prat L Capsule do not require medical attention as they may disappear as your body adjusts to the medicine. In case these side effects become worse, consult your doctor immediately.
Common side effects include:

• Injection site soreness
• Fever
• Loss of appetite
• Drowsiness
• Irritability

• Priorix Vaccine should be given by an experienced nurse or doctor. Please do not self-administer. The first dose of this injection is usually given at 12 through 15 months of age. And the second dose is given at 4 through 6 years of age.
• Never skip any dose and don't forget to follow doctors instructions to get maximum benefit.
  
  

• Priorix Vaccine is a prescription based medicine. It is a combination of three vaccines such as Measles Vaccine (Live) (1000ccid50), Mumps Virus Vaccine (5000ccid50), and Rubella vaccine (Live) (1000ccid50).
• This vaccine helps to develop immunity by initiating a mild infection also this type of infection does not cause illness. Mild infection caused by vaccine stimulate the body's immune system to produce antibodies to protect against any future infections.
  
  

• Di Pietrantonj, C., Rivetti, A., Marchione, P., Debalini, M. G., & Demicheli, V. (2020). Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database of Systematic Reviews, (4).
• Sood, A., Mitra, M., Joshi, H. A., Nayak, U. S., Siddaiah, P., Babu, T. R., ... & Glueck, R. (2017). Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial. Human Vaccines & Immunotherapeutics, 13(7), 1523-1530.
• Larenas-Linnemann, D. E., & Rodríguez-Monroy, F. (2021). Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: All mild course. Allergy, 76(3), 910-914.
• Shah, A. K. (2019). 3.8 MEASLES, MUMPS, AND RUBELLA VACCINES. IAP Guidebook on Immunization, 227.
• Agrawal, R. (2021). 21 Measles, Mumps and Rubella Vaccines MR/MMR/MMRV Vaccines. IAP Q & A on Vaccines & Vaccinology, 204.